10 found
Order:
  1.  18
    Returning Individual Research Results from Digital Phenotyping in Psychiatry.Francis X. Shen, Matthew L. Baum, Nicole Martinez-Martin, Adam S. Miner, Melissa Abraham, Catherine A. Brownstein, Nathan Cortez, Barbara J. Evans, Laura T. Germine, David C. Glahn, Christine Grady, Ingrid A. Holm, Elisa A. Hurley, Sara Kimble, Gabriel Lázaro-Muñoz, Kimberlyn Leary, Mason Marks, Patrick J. Monette, Jukka-Pekka Onnela, P. Pearl O’Rourke, Scott L. Rauch, Carmel Shachar, Srijan Sen, Ipsit Vahia, Jason L. Vassy, Justin T. Baker, Barbara E. Bierer & Benjamin C. Silverman - 2024 - American Journal of Bioethics 24 (2):69-90.
    Psychiatry is rapidly adopting digital phenotyping and artificial intelligence/machine learning tools to study mental illness based on tracking participants’ locations, online activity, phone and text message usage, heart rate, sleep, physical activity, and more. Existing ethical frameworks for return of individual research results (IRRs) are inadequate to guide researchers for when, if, and how to return this unprecedented number of potentially sensitive results about each participant’s real-world behavior. To address this gap, we convened an interdisciplinary expert working group, supported by (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   10 citations  
  2.  30
    AI Surveillance during Pandemics: Ethical Implementation Imperatives.Carmel Shachar, Sara Gerke & Eli Y. Adashi - 2020 - Hastings Center Report 50 (3):18-21.
    Artificial intelligence surveillance can be used to diagnose individual cases, track the spread of Covid‐19, and help provide care. The use of AI for surveillance purposes (such as detecting new Covid‐19 cases and gathering data from healthy and ill individuals) in a pandemic raises multiple concerns ranging from privacy to discrimination to access to care. Luckily, there exist several frameworks that can help guide stakeholders, especially physicians but also AI developers and public health officials, as they navigate these treacherous shoals. (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   3 citations  
  3.  18
    COVID-19 Antibody Testing as a Precondition for Employment: Ethical and Legal Considerations.Sara Gerke, Gali Katznelson, Dorit Reiss & Carmel Shachar - 2021 - Journal of Law, Medicine and Ethics 49 (2):293-302.
    Employers and governments are interested in the use of serological testing to allow people to return to work before there is a vaccine for SARS-CoV-2. We articulate the preconditions needed for the implementation of antibody testing, including the role of the U.S. Food & Drug Administration.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  4.  13
    Consumer genetic technologies: ethical and legal considerations.I. Glenn Cohen, Nita A. Farahany, Henry T. Greely & Carmel Shachar (eds.) - 2021 - New York, NY: Cambridge University Press.
    For the average person, genetic testing has two very different faces. The rise of genetic testing is often promoted as the democratization of genetics by enabling individuals to gain insights into their unique makeup. At the same time, many have raised concerns that genetic testing and sequencing reveal intensely personal and private information. As these technologies become increasingly available as consumer products, the ethical, legal, and regulatory challenges presented by genomics are ever looming. Assembling multidisciplinary experts, this volume evaluates the (...)
    Direct download  
     
    Export citation  
     
    Bookmark  
  5. Transparency in Health and Health Care.I. Glenn Cohen, Barbara Evans, Holly Lynch & Carmel Shachar (eds.) - 2019 - Cambridge UP.
    No categories
     
    Export citation  
     
    Bookmark  
  6.  16
    Recent Developments in Health Law.Won Bok Lee, Carmel Shachar & Peter Chang - 2008 - Journal of Law, Medicine and Ethics 36 (1):191-199.
    In May of 2006, the Abigail Alliance for Better Access to Development Drugs appeared to have won a victory when a divided panel of the Court of Appeals for the District of Columbia Circuit ruled that “terminally ill, mentally competent adult patients” had a constitutionally protected right to access investigational medications. This victory was short lived, however. On August 7, 2007, the D.C. Circuit sitting en banc reversed this earlier decision, marking a setback in Abigail's campaign for removal of the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  7.  13
    Recent Developments in Health Law.Won Bok Lee, Carmel Shachar & Peter Chang - 2008 - Journal of Law, Medicine and Ethics 36 (1):191-199.
    In May of 2006, the Abigail Alliance for Better Access to Development Drugs appeared to have won a victory when a divided panel of the Court of Appeals for the District of Columbia Circuit ruled that “terminally ill, mentally competent adult patients” had a constitutionally protected right to access investigational medications. This victory was short lived, however. On August 7, 2007, the D.C. Circuit sitting en banc reversed this earlier decision, marking a setback in Abigail's campaign for removal of the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  8.  9
    Assigning and Empowering Moral Decision Making: Acuna v. Turkish and Wrongful Birth and Wrongful Life Jurisprudence in New Jersey.Carmel Shachar - 2008 - Journal of Law, Medicine and Ethics 36 (1):193-196.
    The New Jersey Supreme Court has continually avoided making moral judgments about the value of life and emphasized that such decision making should be the province of the potential parents. Recently, in Acuna v. Turkish, the court elaborated on the limitations of the decision-making right of the potential parents, and its decision demonstrated that New Jersey courts were only willing to require physicians to disclose all relevant medical information, and not moral statements that had not been agreed upon by the (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  9.  31
    Recent Developments in Health Law.Carmel Shachar & Pooja Nair - 2009 - Journal of Law, Medicine and Ethics 37 (3):523-530.
    In order for the Food and Drug Administration to receive the trust and deference it needs to accomplish its mission, it must be seen as relatively impervious to political manipulation. For most of the FDA’s history, it has been seen as an institution driven by scientific expertise, not by political maneuvering. However, the FDA was increasingly criticized during the Bush administration for politicizing decisions such as rejecting an application to grant the “morning after pill,” known as Plan B, over-the-counter status (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  10.  16
    Recent Developments in Health Law.Carmel Shachar & Pooja Nair - 2009 - Journal of Law, Medicine and Ethics 37 (3):523-527.
    In order for the Food and Drug Administration to receive the trust and deference it needs to accomplish its mission, it must be seen as relatively impervious to political manipulation. For most of the FDA’s history, it has been seen as an institution driven by scientific expertise, not by political maneuvering. However, the FDA was increasingly criticized during the Bush administration for politicizing decisions such as rejecting an application to grant the “morning after pill,” known as Plan B, over-the-counter status (...)
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark